Singapore’s Health Sciences Authority (HSA) has announced the launch of the new Regulatory Innovation Corridor with the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA). This new coordinated fast-track pathway will enable developers to engage both regulators early and concurrently, accelerating access to breakthrough health technologies in both jurisdictions.
The HSA highlighted that this initiative